Skip to main content
European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

Description du projet

Une révolution pour la prise de décision chirurgicale

Les soins périopératoires exigent une prise de décision précise. Ils se heurtent également à des difficultés liées à l’interprétation subjective de l’imagerie médicale et aux limites de la vision globale de l’anatomie du patient. Dans ce contexte, le projet HoloSurge, financé par l’UE, fusionne l’IA et l’imagerie médicale. Il automatise la fusion des modalités d’imagerie, offrant une visualisation holographique 3D et une navigation chirurgicale en temps réel. Son diagnostic du cancer au niveau cellulaire promet un aperçu inégalé de l’anatomie et de la pathologie des patients. Menée par des scientifiques et des cliniciens européens, cette innovation entend réduire les risques chirurgicaux, en particulier lors d’interventions oncologiques, ce qui pourrait sauver de nombreuses vies. HoloSurge annonce une nouvelle ère de soins périopératoires éclairés, prête à redéfinir les résultats chirurgicaux.

Objectif

Perioperative care is an intricate process that encompasses 1) preoperative evaluation, surgical planning and preparation; 2) intraoperative procedure; and 3) postoperative management. Perioperative care depends on clinical decision-making, a continuous process that involves many healthcare professionals (incl. radiologists, surgeons, anaesthesiologists, nurses, and others) who – based on the best available evidence, clinical experience, and the patient's individual circumstances – make informed decisions on the best course of action. Even though advancements in medical imaging modalities (CT, MRI, ultrasound) have greatly improved surgical outcomes, their interpretation towards deciding a specific course of action remains subjective. In addition, these modalities have several limitations when used alone (e.g. missed lesions; cannot provide a 3D visualization of key structures such as vessels), ultimately failing to provide a full picture of the patient’s anatomy that is shared and unambiguously understood by all in the assigned team. Due to these limitations, there are often suboptimal decisions that add to a cumulative risk of surgical complications in perioperative care.

HoloSurge is a joint undertaking that brings European scientists and clinicians from high-tech companies, clinical centres, and research institutions in a consortium to deploy an innovative AI-based medical system that: i) enables automatic fusion and segmentation of state-of-the-art imaging modalities for interactive 3D holographic visualization of patients’ organs; ii) provides real-time surgical navigation; and iii) allows real-time cell-level cancer diagnostics. The solution will provide surgical teams with an unmatched holistic view of the patient’s anatomy and pathology in real-time at point of care, before and during surgery. This innovation will be validated for cancer interventions, while creating a trail of better-informed perioperative decision-making that can save countless lives.

Coordinateur

HOLOCARE AS
Contribution nette de l'UE
€ 1 951 978,88
Adresse
MOLLERGATA 6 MESH YOUNGSTORGET
0179 OSLO
Norvège

Voir sur la carte

PME

L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.

Oui
Région
Norge Oslo og Viken Oslo
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 2 788 541,25

Participants (10)

Partenaires (4)